Hepatocellular Carcinoma Patients with Hepatitis B Virus Infection Exhibited Favorable Survival from Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
Background: Immune checkpoint inhibitors (ICIs) have demonstrated effectiveness for advanced hepatocellular carcinoma (HCC). However, the discrepancy in the efficacy of ICIs in HCC patients with distinct etiologies has not been systematically validated. Methods: PubMed, MEDLINE, Embase, clinicaltria...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Karger Publishers
2023-10-01
|
| Schriftenreihe: | Liver Cancer |
| Schlagworte: | |
| Online-Zugang: | https://beta.karger.com/Article/FullText/534446 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|